89bio, Inc. (ETNB)Â
NASDAQ$8.52
Market Cap
$1.24B
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
6 of 922
Rank in Industry
5 of 526
Insider Buys Sum
Cluster
Trading
Trading
Insider Buys
Quantity
Quantity
Historical
Profitability
Profitability
Investor
Ownership
Ownership
Largest Insider Buys in Sector
ETNB Insider Trading Activity
ETNB Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $50,302,794 | 6 | 67 |
Sells | $873,298 | 3 | 33 |
Related Transactions
| RA CAPITAL MANAGEMENT, L.P. | 1 | $50M | 0 | $0 | $50M | |
| McWherter Charles | director | 3 | $179,850 | 0 | $0 | $179,850 |
| PALEKAR ROHAN | Chief Executive Officer | 2 | $122,950 | 1 | $575,153 | $-452,203 |
| Le-Nguyen Quoc | See Remarks | 0 | $0 | 2 | $298,144 | $-298,144 |
About 89bio, Inc.
89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also intends to develop pegozafermin for the treatment of severe hypertriglyceridemia. 89bio, Inc. was incorporated in 2018 and is headquartered in San Francisco, California.
Insider Activity of 89bio, Inc.
Over the last 12 months, insiders at 89bio, Inc. have bought $50.3M and sold $873,298 worth of 89bio, Inc. stock.
On average, over the past 5 years, insiders at 89bio, Inc. have bought $48.01M and sold $4.55M worth of stock each year.
Highest buying activity among insiders over the last 12 months: RA CAPITAL MANAGEMENT, L.P. () — $50M. McWherter Charles (director) — $179,850. PALEKAR ROHAN (Chief Executive Officer) — $122,950.
The last purchase of 5,714,285 shares for transaction amount of $50M was made by RA CAPITAL MANAGEMENT, L.P. () on 2025‑01‑30.
List of Insider Buy and Sell Transactions, 89bio, Inc.
| 2025-01-30 | RA CAPITAL MANAGEMENT, L.P. | 5.71M 4.871% | $8.75 | $50M | -3.89% | |||
| 2025-01-22 | McWherter Charles | director | 10,000 0.0085% | $6.71 | $67,100 | +36.59% | ||
| 2025-01-21 | McWherter Charles | director | 5,000 0.0042% | $6.55 | $32,750 | +38.53% | ||
| 2025-01-15 | Sale | Le-Nguyen Quoc | See Remarks | 10,963 0.0096% | $6.49 | $71,150 | +43.54% | |
| 2024-12-06 | PALEKAR ROHAN | Chief Executive Officer | 5,000 0.0041% | $7.89 | $39,450 | +2.17% | ||
| 2024-12-05 | McWherter Charles | director | 10,000 0.0086% | $8.00 | $80,000 | +3.68% | ||
| 2024-11-22 | PALEKAR ROHAN | Chief Executive Officer | 10,000 0.0081% | $8.35 | $83,500 | -4.68% | ||
| 2024-10-30 | Sale | Le-Nguyen Quoc | See Remarks | 27,955 0.0268% | $8.12 | $226,995 | +6.38% | |
| 2024-04-01 | Sale | PALEKAR ROHAN | Chief Executive Officer | 52,718 0.0573% | $10.91 | $575,153 | -21.06% | |
| 2024-03-04 | RA CAPITAL MANAGEMENT, L.P. | 1.35M 1.6718% | $15.35 | $20.72M | -37.80% | |||
| 2024-02-26 | Sale | PALEKAR ROHAN | Chief Executive Officer | 4,477 0.0047% | $10.76 | $48,173 | -21.94% | |
| 2023-12-29 | Sale | PALEKAR ROHAN | Chief Executive Officer | 50,000 0.0549% | $11.20 | $560,000 | -21.53% | |
| 2023-07-17 | Sale | LAPORTE KATHLEEN | director | 12,500 0.024% | $18.80 | $235,000 | -44.87% | |
| 2023-06-05 | Sale | PALEKAR ROHAN | Chief Executive Officer | 15,000 0.0282% | $20.00 | $300,000 | -44.70% | |
| 2023-06-01 | Sale | Atkinson Edward Morrow III | director | 6,250 0.0112% | $17.91 | $111,938 | -41.26% | |
| 2023-05-09 | Sale | Le-Nguyen Quoc | See Remarks | 13,683 0.0258% | $18.11 | $247,799 | -36.44% | |
| 2023-04-04 | Sale | Martins Ryan | Chief Financial Officer | 8,721 0.0165% | $14.95 | $130,379 | -2.83% | |
| 2023-03-28 | Hayden Michael R | director | 61,538 0.112% | $16.15 | $993,839 | -10.96% | ||
| 2023-03-24 | RA CAPITAL MANAGEMENT, L.P. | 2.46M 4.6238% | $16.25 | $40M | -7.31% | |||
| 2023-03-23 | Sale | PALEKAR ROHAN | Chief Executive Officer | 15,000 0.0266% | $16.00 | $240,000 | -10.92% |
Total: 75
*Gray background shows transactions not older than one year
Insider Historical Profitability
32.56%
| RA CAPITAL MANAGEMENT, L.P. | 19554319 13.3948% | $166.6M | 11 | 0 | <0.0001% | |
| PALEKAR ROHAN | Chief Executive Officer | 471236 0.3228% | $4.01M | 6 | 5 | <0.0001% |
| Le-Nguyen Quoc | See Remarks | 271833 0.1862% | $2.32M | 0 | 4 | |
| McWherter Charles | director | 25000 0.0171% | $213,000.00 | 3 | 0 | |
| Shah Rajeev M. | 7782669 5.3312% | $66.31M | 1 | 0 | +239.97% | |
| Longitude Capital Partners III, LLC | 10 percent owner | 2600877 1.7816% | $22.16M | 2 | 0 | +2.62% |
| Naschitz Anat | 1864721 1.2773% | $15.89M | 1 | 1 | +28.8% | |
| ORBIMED ADVISORS LLC | 10 percent owner | 1829433 1.2532% | $15.59M | 1 | 3 | +28.8% |
| Kariv Tomer | 250000 0.1713% | $2.13M | 1 | 0 | +28.8% | |
| Hayden Michael R | director | 61538 0.0422% | $524,303.76 | 8 | 0 | +100.22% |
| Martins Ryan | Chief Financial Officer | 53578 0.0367% | $456,484.56 | 0 | 7 | |
| LAPORTE KATHLEEN | director | 0 0% | $0 | 0 | 1 | |
| Grunberg Gregory | director | 0 0% | $0 | 2 | 1 | +2.62% |
| Waisbourd Ram | See Remarks | 0 0% | $0 | 0 | 15 | |
| Atkinson Edward Morrow III | director | 0 0% | $0 | 0 | 2 |
*Gray background shows insiders who have made transactions during last year
Historical Insider Profitability vs. Competitors
$8,217,280 | 112 | 46.33% | $1.22B | |
$831,902,292 | 108 | 9.34% | $1.58B | |
$20,297,544 | 73 | 103.06% | $1.67B | |
$54,590,806 | 65 | 21.84% | $1.19B | |
$1,101,324,300 | 58 | 37.37% | $1.22B | |
$100,002,191 | 42 | 21.48% | $1.28B | |
89bio, Inc. (ETNB) | $309,951,506 | 30 | 32.56% | $1.24B |
$1,295,059 | 29 | 102.78% | $1.3B | |
$7,598,498 | 27 | 34.68% | $1.17B | |
$169,638,586 | 22 | 30.82% | $1.16B | |
$43,198,628 | 12 | -0.10% | $1.24B | |
$2,834,855 | 9 | 34.92% | $1.18B | |
$45,445,266 | 9 | -24.96% | $1.61B | |
$1,229,547 | 7 | 11.98% | $1.16B | |
$107,703,099 | 7 | 29.71% | $1.47B | |
$91,325,021 | 6 | 1.83% | $1.37B | |
$8,503,480 | 3 | 132.88% | $1.2B | |
$142,493,653 | 3 | 4.30% | $1.7B | |
$5,000,000 | 1 | -22.84% | $1.25B |
ETNB Institutional Investors: Active Positions
| Increased Positions | 108 | +83.08% | 25M | +23.79% |
| Decreased Positions | 57 | -43.85% | 8M | -7.33% |
| New Positions | 33 | New | 8M | New |
| Sold Out Positions | 22 | Sold Out | 2M | Sold Out |
| Total Postitions | 181 | +39.23% | 122M | +16.46% |
ETNB Ownership Change vs Market
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
| Janus Henderson Group Plc | $139,874.00 | 11.31% | 16.51M | +1M | +8.95% | 2024-12-31 |
| Ra Capital Management, L.P. | $120,066.00 | 9.71% | 14.18M | 0 | 0% | 2024-12-31 |
| Suvretta Capital Management, Llc | $86,417.00 | 6.99% | 10.2M | +2M | +27.67% | 2024-12-31 |
| Blackrock, Inc. | $66,829.00 | 5.4% | 7.89M | +340,797 | +4.51% | 2024-12-31 |
| Rtw Investments, Lp | $63,339.00 | 5.12% | 7.48M | +99,513 | +1.35% | 2024-12-31 |
| Deep Track Capital, Lp | $54,871.00 | 4.44% | 6.48M | +4M | +134.17% | 2024-12-31 |
| Vanguard Group Inc | $48,214.00 | 3.9% | 5.69M | +686,054 | +13.7% | 2024-12-31 |
| Citadel Advisors Llc | $40,062.00 | 3.24% | 4.73M | +2M | +85% | 2024-12-31 |
| Bvf Inc/Il | $36,708.00 | 2.97% | 4.33M | -2M | -36.38% | 2024-12-31 |
| Avoro Capital Advisors Llc | $34,727.00 | 2.81% | 4.1M | +4M | New | 2024-12-31 |
Financial Ratios
Summary
Comparison with Competitors
Analyst Recommendations
Analyst Price Targets
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.